Oxidative modification of apolipoprotein E in human very-low-density lipoprotein and its inhibition by glycosaminoglycans

被引:50
|
作者
Arai, H
Kashiwagi, S
Nagasaka, Y
Uchida, K
Hoshii, Y
Nakamura, K
机构
[1] Yamaguchi Univ, Sch Med, Dept Biochem 1, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Prefectural Univ, Dept Nutr, Yamaguchi 7538502, Japan
[3] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan
[4] Nagoya Univ, Sch Agr Sci, Lab Food & Biodynam, Nagoya, Aichi 46401, Japan
[5] Yamaguchi Univ, Sch Med, Dept Pathol 1, Ube, Yamaguchi 7558505, Japan
[6] Yamaguchi Univ, Sch Med, Cent Lab Biomed Res & Educ, Ube, Yamaguchi 7558505, Japan
关键词
apolipoprotein E; very-low-density lipoprotein; metal ion; radical; oxidation; glycosaminoglycan;
D O I
10.1006/abbi.1999.1222
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism of metal ion-catalyzed oxidative modification of apolipoprotein E (apoE) in human very-low-density lipoprotein (VLDL) and its inhibition by glycosaminoglycan (GAG) was investigated in vitro, The VLDL oxidation catalyzed by Cu2+ led to the lipid peroxidation, the formation of aggregates, and covalent modification of apoE, The modified apoE lost heparin-binding activity. These results suggest that the lipid peroxidation of VLDL and modification of apoE cause impairment of lipid uptake by cells and deposit the oxidized lipids in the tissues. The lipid peroxidation and oxidative modification of apoE in VLDL mediated by Cu2+ and an aqueous radical generator were suppressed by GAG, heparan sulfate, heparin, and chondroitin sulfate A, even though GAGs demonstrated no ability to scavenge alpha,alpha-diphenyl-beta-picrylhydrazyl radical. There were no relationships between inhibitory activity of GAGs in the VLDL oxidation and their number of sulfate groups which possess chelating activity of metal ion. Therefore, it can be considered that the inhibition of VLDL oxidation by GAGs is possibly due to the interaction between GAG and VLDL which bring about the steric hindrance, interference with the reaction between VLDL particle and the reactive oxygen species. These studies suggest that GAGs preserve the biological functions of apoE from oxidative stress. (C) 1999 Academic Press.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] LOW-DENSITY LIPOPROTEIN RECEPTOR-BINDING DETERMINANTS SWITCH FROM APOLIPOPROTEIN E TO APOLIPOPROTEIN-B DURING CONVERSION OF HYPERTRIGLYCERIDEMIC VERY-LOW-DENSITY LIPOPROTEIN TO LOW-DENSITY LIPOPROTEINS
    BRADLEY, WA
    HWANG, SLC
    KARLIN, JB
    LIN, AHY
    PRASAD, SC
    GOTTO, AM
    GIANTURCO, SH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (23) : 4728 - 4735
  • [22] HUMAN VERY-LOW-DENSITY LIPOPROTEIN STRUCTURE - INTERACTION OF THE C-APOLIPOPROTEINS WITH APOLIPOPROTEIN B-100
    YANG, CY
    GU, ZW
    VALENTINOVA, N
    POWNALL, HJ
    LEE, B
    YANG, M
    XIE, YH
    GUYTON, JR
    VLASIK, TN
    FRUCHART, JC
    GOTTO, AM
    JOURNAL OF LIPID RESEARCH, 1993, 34 (08) : 1311 - 1321
  • [23] ENHANCEMENT OF THE BINDING OF TRIGLYCERIDE-RICH LIPOPROTEINS TO THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR BY APOLIPOPROTEIN-E AND LIPOPROTEIN-LIPASE
    TAKAHASHI, S
    SUZUKI, J
    KOHNO, M
    OIDA, K
    TAMAI, T
    MIYABO, S
    YAMAMOTO, T
    NAKAI, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (26) : 15747 - 15754
  • [24] APOLIPOPROTEIN-E AND LIPOPROTEIN-LIPASE ACCELERATE THE BINDING OF TRIGLYCERIDE-RICH LIPOPROTEINS TO THE VERY-LOW-DENSITY LIPOPROTEIN RECEPTOR
    TAKAHASHI, S
    SUZUKI, J
    OIDA, K
    MIYABO, S
    YAMAMOTO, T
    NAKAI, T
    CIRCULATION, 1994, 90 (04) : 2 - 2
  • [25] INHIBITION OF OXIDATIVE MODIFICATION OF HUMAN LOW-DENSITY-LIPOPROTEIN BY DARK BEER
    WHITEHEAD, R
    LANNINGHAM, L
    LOO, G
    FASEB JOURNAL, 1995, 9 (04): : A893 - A893
  • [26] THE BINDING OF VERY-LOW-DENSITY LIPOPROTEIN REMNANTS TO THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IN FAMILIAL DEFECTIVE APOLIPOPROTEIN-B-100
    MAHER, VMG
    GALLAGHER, JJ
    MYANT, NB
    ATHEROSCLEROSIS, 1993, 102 (01) : 51 - 61
  • [27] Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
    Mendivil, Carlos O.
    Zheng, Chunyu
    Furtado, Jeremy
    Lel, Julian
    Sacks, Frank M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 239 - U210
  • [28] INCREASED HEPATIC SECRETION OF VERY-LOW-DENSITY LIPOPROTEIN APOLIPOPROTEIN B-100 IN NIDDM
    CUMMINGS, MH
    WATTS, GF
    UMPLEBY, AM
    HENNESSY, TR
    NAOUMOVA, R
    SLAVIN, BM
    THOMPSON, GR
    SONKSEN, PH
    DIABETOLOGIA, 1995, 38 (08) : 959 - 967
  • [29] STUDIES OF A VARIANT VERY-LOW-DENSITY LIPOPROTEIN WITH AN ACQUIRED DEFICIENCY OF APOLIPOPROTEIN-C-II
    RECKLESS, JPD
    STOCKS, J
    HOLDSWORTH, G
    GALTON, DJ
    SUGGETT, AJ
    WALTON, KW
    CLINICAL SCIENCE, 1982, 62 (01) : 93 - 100
  • [30] Molecular characterization of quail apolipoprotein very-low-density lipoprotein II: Disulphide-bond-mediated dimerization is not essential for inhibition of lipoprotein lipase
    MacLachlan, I
    Steyrer, E
    Hermetter, A
    Nimpf, J
    Schneider, WJ
    BIOCHEMICAL JOURNAL, 1996, 317 : 599 - 604